Glioma-released exosomal miR-3591-3p promotes macrophage to the M2 phenotype by targeting CBLB to activate the JAK2/PI3K/Akt/mTOR and STAT3, thereby promoting glioma progression. Here, AKT1 is linked to central nervous system cancer.